Generate Biomedicines, Inc.

US$13.06As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:GENBHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$1.676B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$17
27.72%
(87.59%)
Hold 4|4|1|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.13
0.14
0.16
0.17
4.10%
17.28%
19.55%
27.57%
Revenue$M
80.04
82.88
84.74
86.91
10.18%
7.68%
6.59%
7.21%
Peers (US$1.676B)
Cap (US$)
PE
1.672B
5.690x
1.673B
—
Capital
TTM
5Y
10Y
Leveragex
2.955
0.095
0.080
EBIT/Intx
0.134
0.043
0.057
Own earn%
(190.42)
(81.39)
(71.42)
Sh yield%
25.57
36.68
33.34
Owners
Insiders/Inst%
9.05
54.86
Short interest%
2.12
SBC / revenue%
4.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
8–14
$1 testx
—
Incr. ROIC%
1